본문으로 건너뛰기
← 뒤로

Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy.

1/5 보강
Immunology 📖 저널 OA 37.9% 2024: 0/1 OA 2025: 2/6 OA 2026: 9/22 OA 2024~2026 2024 Vol.172(3) p. 343-361
Retraction 확인
출처

Wu Q, Mao H, Jiang Z, Tang D

📝 환자 설명용 한 줄

Pancreatic cancer (PC) is a highly malignant tumour of the digestive system with poor therapeutic response and low survival rates.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Wu Q, Mao H, et al. (2024). Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy.. Immunology, 172(3), 343-361. https://doi.org/10.1111/imm.13765
MLA Wu Q, et al.. "Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy.." Immunology, vol. 172, no. 3, 2024, pp. 343-361.
PMID 38402904 ↗
DOI 10.1111/imm.13765

Abstract

Pancreatic cancer (PC) is a highly malignant tumour of the digestive system with poor therapeutic response and low survival rates. Immunotherapy has rapidly developed in recent years and has achieved significant outcomes in numerous malignant neoplasms. However, responses to immunotherapy in PC are rare, and the immunosuppressive and desmoplastic tumour microenvironment (TME) significantly hinders their efficacy in PC. Tumour-associated neutrophils (TANs) play a crucial role in the PC microenvironment and exert a profound influence on PC immunotherapy by establishing a robust stromal shelter and restraining immune cells to assist PC cells in immune escape, which may subvert the current status of PC immunotherapy. The present review aims to offer a comprehensive summary of the latest progress in understanding the involvement of TANs in PC desmoplastic and immunosuppressive functions and to emphasise the potential therapeutic implications of focusing on TANs in the immunotherapy of this deleterious disease. Finally, we provide an outlook for the future use of TANs in PC immunotherapy.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반